Company Filing History:
Years Active: 2016-2017
Title: Daniele Lecis: Innovator in Apoptosis Induction
Introduction
Daniele Lecis is a notable inventor based in Arese, Italy. He has made significant contributions to the field of cancer therapy through his innovative work on SMAC mimetic compounds. With a total of 2 patents, Lecis is recognized for his advancements in apoptosis inducers.
Latest Patents
Lecis's latest patents focus on homo- and heterodimeric SMAC mimetic compounds that serve as apoptosis inducers. These inventions relate to conformationally constrained mimetics of Smac, which function as inhibitors of Inhibitor of Apoptosis Proteins (IAPs). The therapeutic applications of these compounds are particularly beneficial in inducing apoptotic cell death, especially in cancer treatment, either alone or in combination with other active ingredients.
Career Highlights
Daniele Lecis is currently associated with BioNTech AG, where he continues to develop innovative solutions in the realm of cancer therapy. His work is characterized by a commitment to advancing medical science and improving patient outcomes.
Collaborations
Lecis collaborates with esteemed colleagues such as Pierfausto Seneci and Laura Belvisi, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Daniele Lecis stands out as a prominent inventor in the field of apoptosis induction, with his work paving the way for new cancer therapies. His contributions are vital to the ongoing fight against cancer, showcasing the importance of innovation in medicine.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.